We are live on
!
Find out more
MYIA
Mount Yale Investment Advisors Portfolio holdings
AUM
$4.31B
1-Year Est. Return
21.13%
This Fund
S&P 500
This Quarter
Est. Return
-4.25%
1 Year Est. Return
+21.13%
3 Year Est. Return
+69.37%
5 Year Est. Return
+92.43%
10 Year Est. Return
–
AUM
$920M
AUM Growth
-$42.1M
(-4.4%)
Cap. Flow
+$13.3M
Cap. Flow
% of AUM
1.45%
Top 10 Holdings %
Top 10 Hldgs %
29.38%
Holding
508
New
52
Increased
220
Reduced
173
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$6.78M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$2.73M |
| 3 |
Ferguson
FERG
|
+$2.29M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$2.22M |
| 5 |
IBM
IBM
|
+$1.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.57M |
| 2 |
iShares MSCI EAFE Growth ETF
EFG
|
+$5.41M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$3.3M |
| 4 |
iShares S&P 500 Growth ETF
IVW
|
+$2.81M |
| 5 |
TSMC
TSM
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.63% |
| 2 | Healthcare | 10.88% |
| 3 | Financials | 9.7% |
| 4 | Communication Services | 7.54% |
| 5 | Consumer Discretionary | 6.82% |
Similar funds
GWM
IUHSA
CW
IWM
NEI
NHC
Mount Yale Investment Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Mount Yale Investment Advisors held 508 positions worth $920M, down 4.4% from $962M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Mount Yale Investment Advisors's Q1 2022 filing shows 52 new, 220 increased, 173 reduced and 46 closed positions. Its largest new stake was Gilead Sciences: 105,999 shares worth $6.3M. The largest sale was Bristol-Myers Squibb, an estimated $6.57M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Mount Yale Investment Advisors's largest Q1 2022 buy was Gilead Sciences: 105,999 shares worth $6.3M.
- Mount Yale Investment Advisors added most to iShares Core S&P Total US Stock Market ETF in Q1 2022, an estimated $2.73M increase.
- Mount Yale Investment Advisors's biggest Q1 2022 reduction was Bristol-Myers Squibb, cutting an estimated $6.57M.
- Mount Yale Investment Advisors fully exited iShares S&P 500 Growth ETF in Q1 2022, selling an estimated $2.81M.
- Mount Yale Investment Advisors's ten largest holdings make up 29% of its $920M portfolio in Q1 2022.
- Mount Yale Investment Advisors opened 52 new positions and closed 46 in Q1 2022.
- Mount Yale Investment Advisors's portfolio value fell 4.4% quarter-over-quarter to $920M.
Based on Mount Yale Investment Advisors's 13F filing for Q1 2022, filed 3 May 2022.